ARCHIVES

In Brief: Columbia’s Marks Reportedly Will Move To MSK; FDA Committee to Consider THC For Group C List

This article is from The Cancer Letter archive.

Vol. 06 No. 21 | May 23, 1980

Download PDF Visit The Full Archive

Related Articles

DCT Board Delays Action On Protein Index, Refuses Support for Cow Study, Approves Various Concepts

October 16, 1981

Senate Subcommittee Oks $850Million for Cancer; NCI Reveals How It Would Spend Fiscal 1978 Funds

June 18, 1976

8 Centers Awarded Comprehensive Designation

February 15, 1991

NCI-Approved Clinical Trials

May 28, 2004

Xgeva Significantly Increases Bone Metastasis-Free Survival

May 27, 2011

Advocacy Groups Form Council To Lobby For Cancer Programs To Benefit Minorities

April 28, 1995